Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Basket Trial of Pembrolizumab in Patients With Advanced Solid Tumors and Genomic Instability

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03428802
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:04.260358+00:00
Published At
2026-04-03T00:00:00+00:00
Record Updated At
2026-04-03
Results Posted At
2026-04-03
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["BRCA1 Gene Mutation", "BRCA2 Gene Mutation", "Locally Advanced Solid Neoplasm", "Metastatic Malignant Solid Neoplasm", "POLD1 Gene Mutation", "POLE Gene Mutation", "Recurrent Malignant Solid Neoplasm", "Recurrent Ovarian Carcinoma", "Stage III Breast Cancer AJCC v7", "Stage III Ovarian Cancer AJCC v8", "Stage IIIA Breast Cancer AJCC v7", "Stage IIIA Ovarian Cancer AJCC v8", "Stage IIIB Breast Cancer AJCC v7", "Stage IIIB Ovarian Cancer AJCC v8", "Stage IIIC Breast Cancer AJCC v7", "Stage IIIC Ovarian Cancer AJCC v8", "Stage IV Breast Cancer AJCC v6 and v7", "Stage IV Ovarian Cancer AJCC v8", "Stage IVA Ovarian Cancer AJCC v8", "Stage IVB Ovarian Cancer AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-03"
protocolSection.identificationModule.nctId
"NCT03428802"
protocolSection.identificationModule.officialTitle
"A Basket Trial of Pembrolizumab in Patients With Advanced Solid Tumors and Genomic Instability"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2026-04-03"

Study condition terms

  • BRCA1 Gene Mutation (protocolSection.conditionsModule.conditions)
  • BRCA2 Gene Mutation (protocolSection.conditionsModule.conditions)
  • Locally Advanced Solid Neoplasm (protocolSection.conditionsModule.conditions)
  • Metastatic Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)
  • POLD1 Gene Mutation (protocolSection.conditionsModule.conditions)
  • POLE Gene Mutation (protocolSection.conditionsModule.conditions)
  • Recurrent Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)
  • Recurrent Ovarian Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Breast Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage III Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Breast Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Breast Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIC Breast Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIC Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Breast Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.